What changes when materials are combined?
A blend supplies two constituents in a fixed labelled presentation. Separate materials have their own identity, quantity and batch records. Neither format is automatically better; suitability depends on the laboratory specification.
The blend name must retain No DAC where that is the form supplied. Omitting it can cause literature and procurement records to refer to different CJC materials.
Understand the total
A 5 mg plus 5 mg label is 10 mg total. Compare each constituent amount, not a blend total against a single-vial amount. Do not assume that every total-only blend uses equal proportions.
For quotes, record presentation, number of vials, component amounts and current INR totals. Delivery is a separate order cost and should not be hidden in a per-milligram comparison.
Batch documentation and experimental controls
Ask whether the available report identifies both constituents and what quantitative claim, if any, is supported for each. A single peak-purity percentage should not be interpreted as two independent content measurements.
Separate vials can have different lot histories. A blend also requires its own storage and stability information; do not invent compatibility or stability from the constituent names.
How to use the linked records
Open each product page for the live size selector, current price, stock and batch-document request. Keep a copy of the accepted quotation with the material records.
The Ipamorelin pharmacology paper concerns its tested systems, while the long-acting CJC study concerns a different CJC presentation. Neither paper verifies the combined catalogue vial or establishes a human-use protocol.